Multiple Endocrine Neoplasia
This is an inherited autosomal dominant condition that leads to multiple hormoneproducing tumours in endocrine glands. It is divided into three types:
Type 1 is due to a mutation in the MEN1 tumour suppressor gene. In type 1, the most common presentation is hypercalcaemia due to parathyroid hyperplasia
Type 2 is due to a RET oncogene (receptor tyrosine kinase) mutation and is further divided into 2 types.
![multiple endocrine neoplasia](https://b2470160.smushcdn.com/2470160/wp-content/uploads/2020/01/multiple-endocrine-neoplasia.png?lossy=0&strip=1&webp=1)
Multiple Endocrine Neoplasia – Type 1
This is a subtype which consists of the following. 3Ps:
Parathyroid hyperplasia, without altering hormone secretion.
Pituitary prolactinoma/GH tumour – Most of these are prolactinomas, then GH secreting tumours.
Pancreas: insulinoma/gastrinoma – Can lead to Zollinger-Ellison syndrome
Multiple Endocrine Neoplasia – Type 2a
This subtype consists of the following symptoms:
Medullary thyroid cancer
Phaeochromocytoma
Parathyroid hyperplasia
Multiple Endocrine Neoplasia – Type 2b
This subtype consists of the following symptoms:
Medullary thyroid cancer
Phaeochromocytoma
Tall, thin Marfan’s body type
Dry eyes or lack of tears
Delayed puberty
It usually manifests in early childhood
![Picture 1](https://b2470160.smushcdn.com/2470160/wp-content/uploads/2020/01/Picture-1-54.png?lossy=0&strip=1&webp=1)
Management
This involves medical management depending on the hormones affected as well as treatment of the affected glands usually by surgical excision
![](https://medicine-21.com/ru/wp-content/uploads/2023/11/WhatsApp-Image-2023-11-18-at-7.12.10-PM.jpeg)